SCHEMBL28679409

SCHEMBL28679409

N#Cc1ccc(-c2cc(C(=O)Nc3ncc(-c4ccco4)[nH]3)c3ccccc3n2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ STAT3 P40763 3/20 0.54
▸ CACNA1B Q00975 1/20 0.51
▸ APBA1 Q02410 1/20 0.51
▸ MCL1 Q07820 4/20 0.49
▸ KDM4E B2RXH2 6/20 0.49
▸ ALDH1A1 P00352 6/20 0.49
▸ L3MBTL1 Q9Y468 5/20 0.49
▸ POLB P06746 4/20 0.49
▸ MEN1 O00255 4/20 0.49
▸ KMT2A Q03164 4/20 0.49
▸ MAPT P10636 3/20 0.49
▸ CTDSP1 Q9GZU7 3/20 0.49
▸ LMNA P02545 2/20 0.49
▸ SAE1 Q9UBE0 1/20 0.49
▸ UBA2 Q9UBT2 1/20 0.49
▸ TDP1 Q9NUW8 3/20 0.48
▸ APOBEC3A P31941 1/20 0.48
▸ APOBEC3G Q9HC16 1/20 0.48
▸ HPGD P15428 3/20 0.48
▸ THRB P10828 2/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28696288 0.92 CACNA1B (0.53) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28681436 0.91 STAT3 (0.61) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28695985 0.90 STAT3 (0.55) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28673399 0.89 MEN1 (0.58) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28699068 0.89 STAT3 (0.54) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28683183 0.89 CHEK1 (0.58) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28699093 0.87 CTDSP1 (0.62) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28673422 0.86 MEN1 (0.59) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28683197 0.86 STAT3 (0.51) STAT3CACNA1BAPBA1MCL1KDM4E
SCHEMBL28690124 0.84 ALDH1A1 (0.58) STAT3CACNA1BAPBA1MCL1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113747920-A Immune checkpoint inhibitor combination therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-12-03 — — CN disclosed
CN-112703001-A Combination cancer therapy using quinoline carboxamide derivatives 株式会社益力多本社 2021-04-23 — — CN disclosed
Send feedback